These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19690386)

  • 1. Deficiencies in Chfr and Mlh1 synergistically enhance tumor susceptibility in mice.
    Fu Z; Regan K; Zhang L; Muders MH; Thibodeau SN; French A; Wu Y; Kaufmann SH; Lingle WL; Chen J; Tindall DJ
    J Clin Invest; 2009 Sep; 119(9):2714-24. PubMed ID: 19690386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chfr is required for tumor suppression and Aurora A regulation.
    Yu X; Minter-Dykhouse K; Malureanu L; Zhao WM; Zhang D; Merkle CJ; Ward IM; Saya H; Fang G; van Deursen J; Chen J
    Nat Genet; 2005 Apr; 37(4):401-6. PubMed ID: 15793587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHFR promoter hypermethylation in colon cancer correlates with the microsatellite instability phenotype.
    Brandes JC; van Engeland M; Wouters KA; Weijenberg MP; Herman JG
    Carcinogenesis; 2005 Jun; 26(6):1152-6. PubMed ID: 15760919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of CHFR in human mammary epithelial cells causes genomic instability by disrupting the mitotic spindle assembly checkpoint.
    Privette LM; Weier JF; Nguyen HN; Yu X; Petty EM
    Neoplasia; 2008 Jul; 10(7):643-52. PubMed ID: 18592005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of CHFR and MLH1 methylation in human gastric cancer.
    Li Y; Yang Y; Lu Y; Herman JG; Brock MV; Zhao P; Guo M
    Gastric Cancer; 2015 Apr; 18(2):280-7. PubMed ID: 24748501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-proliferative effects of the CHFR depend on the forkhead associated domain, but not E3 ligase activity mediated by ring finger domain.
    Fukuda T; Kondo Y; Nakagama H
    PLoS One; 2008 Mar; 3(3):e1776. PubMed ID: 18335050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
    Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
    Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Checkpoint with forkhead-associated and ring finger promoter hypermethylation correlates with microsatellite instability in gastric cancer.
    Oki E; Zhao Y; Yoshida R; Masuda T; Ando K; Sugiyama M; Tokunaga E; Morita M; Kakeji Y; Maehara Y
    World J Gastroenterol; 2009 May; 15(20):2520-5. PubMed ID: 19469003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?
    van Roon EH; van Puijenbroek M; Middeldorp A; van Eijk R; de Meijer EJ; Erasmus D; Wouters KA; van Engeland M; Oosting J; Hes FJ; Tops CM; van Wezel T; Boer JM; Morreau H
    BMC Cancer; 2010 May; 10():180. PubMed ID: 20444249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ionizing radiation, inflammation, and their interactions in colon carcinogenesis in Mlh1-deficient mice.
    Morioka T; Miyoshi-Imamura T; Blyth BJ; Kaminishi M; Kokubo T; Nishimura M; Kito S; Tokairin Y; Tani S; Murakami-Murofushi K; Yoshimi N; Shimada Y; Kakinuma S
    Cancer Sci; 2015 Mar; 106(3):217-26. PubMed ID: 25529563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic and genetic silencing of CHFR in esophageal adenocarcinomas.
    Soutto M; Peng D; Razvi M; Ruemmele P; Hartmann A; Roessner A; Schneider-Stock R; El-Rifai W
    Cancer; 2010 Sep; 116(17):4033-42. PubMed ID: 20564104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chfr inactivation is not associated to chromosomal instability in colon cancers.
    Bertholon J; Wang Q; Falette N; Verny C; Auclair J; Chassot C; Navarro C; Saurin JC; Puisieux A
    Oncogene; 2003 Dec; 22(55):8956-60. PubMed ID: 14654793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. USP7 and Daxx regulate mitosis progression and taxane sensitivity by affecting stability of Aurora-A kinase.
    Giovinazzi S; Morozov VM; Summers MK; Reinhold WC; Ishov AM
    Cell Death Differ; 2013 May; 20(5):721-31. PubMed ID: 23348568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHFR silencing or microsatellite instability is associated with increased antitumor activity of docetaxel or gemcitabine in colorectal cancer.
    Pelosof L; Yerram SR; Ahuja N; Delmas A; Danilova L; Herman JG; Azad NS
    Int J Cancer; 2014 Feb; 134(3):596-605. PubMed ID: 23873170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHFR protein regulates mitotic checkpoint by targeting PARP-1 protein for ubiquitination and degradation.
    Kashima L; Idogawa M; Mita H; Shitashige M; Yamada T; Ogi K; Suzuki H; Toyota M; Ariga H; Sasaki Y; Tokino T
    J Biol Chem; 2012 Apr; 287(16):12975-84. PubMed ID: 22337872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATR functions as a gene dosage-dependent tumor suppressor on a mismatch repair-deficient background.
    Fang Y; Tsao CC; Goodman BK; Furumai R; Tirado CA; Abraham RT; Wang XF
    EMBO J; 2004 Aug; 23(15):3164-74. PubMed ID: 15282542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced mRNA expression in paraffin-embedded tissue identifies MLH1- and MSH2-deficient colorectal tumours and potential mutation carriers.
    Müller A; Zielinski D; Friedrichs N; Oberschmid B; Merkelbach-Bruse S; Schackert HK; Linnebacher M; von Knebel Doeberitz M; Büttner R; Rüschoff J;
    Virchows Arch; 2008 Jul; 453(1):9-16. PubMed ID: 18581137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter hypermethylation of the Chfr gene in neoplastic and non-neoplastic gastric epithelia.
    Honda T; Tamura G; Waki T; Kawata S; Nishizuka S; Motoyama T
    Br J Cancer; 2004 May; 90(10):2013-6. PubMed ID: 15138487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct effects of the recurrent Mlh1G67R mutation on MMR functions, cancer, and meiosis.
    Avdievich E; Reiss C; Scherer SJ; Zhang Y; Maier SM; Jin B; Hou H; Rosenwald A; Riedmiller H; Kucherlapati R; Cohen PE; Edelmann W; Kneitz B
    Proc Natl Acad Sci U S A; 2008 Mar; 105(11):4247-52. PubMed ID: 18337503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHFR: a key checkpoint component implicated in a wide range of cancers.
    Sanbhnani S; Yeong FM
    Cell Mol Life Sci; 2012 May; 69(10):1669-87. PubMed ID: 22159584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.